SCHEMBL3277262

SCHEMBL3277262

CCOC(=O)c1c(CN(C)C(=O)OCC)c2cc(F)ccc2n1Cc1cccc2ccc(F)cc12

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
PTGDR2 Q9Y5Y4 8/20 0.42
ELANE P08246 2/20 0.40
ALDH1A1 P00352 3/20 0.38
HK1 P19367 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HKDC1 Q2TB90 1/20 0.38
MAPT P10636 4/20 0.37
KDM4E B2RXH2 2/20 0.37
PKM P14618 1/20 0.37
PTGDR Q13258 3/20 0.36
PTGIR P43119 1/20 0.36
GAA P10253 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
LOXL2 Q9Y4K0 1/20 0.36
NOD2 Q9HC29 1/20 0.36
NOD1 Q9Y239 1/20 0.36
THRB P10828 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3275173 0.96 KMT2A (0.46) KMT2AMEN1PTGDR2ELANEALDH1A1
SCHEMBL3281152 0.95 KMT2A (0.49) KMT2AMEN1PTGDR2ELANEALDH1A1
SCHEMBL3277567 0.95 KMT2A (0.43) KMT2AMEN1PTGDR2ELANEALDH1A1
SCHEMBL3277166 0.93 PTGDR2 (0.42) KMT2AMEN1PTGDR2ALDH1A1HK1
SCHEMBL3281136 0.91 KMT2A (0.44) KMT2AMEN1PTGDR2ELANEALDH1A1
SCHEMBL3275046 0.90 MEN1 (0.48) KMT2AMEN1PTGDR2ELANEALDH1A1
SCHEMBL3275427 0.89 KMT2A (0.46) KMT2AMEN1PTGDR2ELANEALDH1A1
SCHEMBL3276388 0.89 PTGDR2 (0.41) KMT2AMEN1PTGDR2ALDH1A1HK1
SCHEMBL3277704 0.89 KMT2A (0.46) KMT2AMEN1PTGDR2ELANEALDH1A1
SCHEMBL3275720 0.88 MCL1 (0.44) KMT2AMEN1PTGDR2ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966134-B1 NOVEL FUSED PYRROLE DERIVATIVES HOFFMANN LA ROCHE (CH) 2014-03-12 EP disclosed
US-7696240-B2 Fused pyrrole derivatives HOFFMANN-LA ROCHE INC. (US) 2010-04-13 US disclosed
US-20070142452-A1 Fused pyrrole derivatives HOFFMANN-LA ROCHE INC. 2007-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142452-A1 Fused pyrrole derivatives CMA1, PREP, CPA3 KMT2A 3786/4885MEN1 2461/4885PTGDR2 414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.